Clinical information
Diagnostic Utility:
This is the qualitative detection of IgG, IgM, IgA antibodies against Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, and Plasmodium malariae) and its determination is useful in:
- Identification of individuals with a chronic infection or past infection of malaria.
- Blood component transfusion.
- Transplantation of progenitor cells, umbilical cord blood cells, solid organs, and tissues.
Method:
Enzyme immunoassay (EIA)
Reference Values
Possible results are: Reactive and Non-Reactive.
Diagnostic Algorithm:
Not applicable
Response Time:
Maximum of 20 working days.
Specimen information
Sample: Serum and/or plasma
Tube: Aliquots of 1-5 mL, plasma tubes with EDTA, sodium citrate, or heparin as anticoagulant, and/or serum tubes with and without gel separator.
Minimum essential volume: 1 ml
Stability:
- At room temperature: ≤ 3 days
- In refrigeration 2-8 ºC: ≤ 7 days
- Frozen sample equal to or below -20ºC: 10 years
Transport instructions: Preferably at room temperature and/or refrigerated if they are whole blood tubes, and frozen if they are serum and/or plasma aliquots.
Reason for rejection: Sample highly hemolyzed or with obvious microbial contamination.
Administrative information
BST Code: 0182
Test Description: Plasmodium sp, Antibodies (IgG, IgM, IgA). Screening
Synonyms: Malaria antibodies
Section: Transfusion Safety Laboratory
BST Rate: Check the updated rates here.
Profiles:
N/A.
References
- Inserts kits test CAPTIA Malària EIA Trinity Biotech
Quality
BST holds ISO 9001, ISO 14001, and OSHAS 18001 quality certifications, as well as the European Excellence 500+ seal. BST is accredited by CAT, JACIE-FACT, FACT-NETCORD, and EFI, and complies with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) guidelines.